"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the human BREAST.
| Descriptor ID |
D001943
|
| MeSH Number(s) |
C04.588.180 C17.800.090.500
|
| Concept/Terms |
Breast Neoplasms- Breast Neoplasms
- Breast Neoplasm
- Neoplasm, Breast
- Breast Tumors
- Breast Tumor
- Tumor, Breast
- Tumors, Breast
- Neoplasms, Breast
Breast Carcinoma- Breast Carcinoma
- Breast Carcinomas
- Carcinoma, Breast
- Carcinomas, Breast
Mammary Neoplasms, Human- Mammary Neoplasms, Human
- Human Mammary Neoplasm
- Human Mammary Neoplasms
- Neoplasm, Human Mammary
- Neoplasms, Human Mammary
- Mammary Neoplasm, Human
Breast Cancer- Breast Cancer
- Cancer, Breast
- Mammary Cancer
- Cancer, Mammary
- Cancers, Mammary
- Mammary Cancers
- Malignant Neoplasm of Breast
- Breast Malignant Neoplasm
- Breast Malignant Neoplasms
- Malignant Tumor of Breast
- Breast Malignant Tumor
- Breast Malignant Tumors
- Cancer of Breast
- Cancer of the Breast
|
Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".
This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 3 | 1 | 4 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 3 | 2 | 5 |
| 2002 | 7 | 1 | 8 |
| 2003 | 11 | 1 | 12 |
| 2004 | 8 | 4 | 12 |
| 2005 | 5 | 1 | 6 |
| 2006 | 10 | 0 | 10 |
| 2007 | 9 | 0 | 9 |
| 2008 | 7 | 1 | 8 |
| 2009 | 14 | 1 | 15 |
| 2010 | 16 | 7 | 23 |
| 2011 | 12 | 2 | 14 |
| 2012 | 8 | 1 | 9 |
| 2013 | 7 | 6 | 13 |
| 2014 | 11 | 3 | 14 |
| 2015 | 15 | 1 | 16 |
| 2016 | 16 | 2 | 18 |
| 2017 | 15 | 0 | 15 |
| 2018 | 18 | 1 | 19 |
| 2019 | 15 | 2 | 17 |
| 2020 | 21 | 1 | 22 |
| 2021 | 20 | 1 | 21 |
| 2022 | 16 | 0 | 16 |
| 2023 | 9 | 0 | 9 |
| 2024 | 6 | 1 | 7 |
| 2025 | 10 | 1 | 11 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.
-
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ. Breast Cancer Res. 2026 Jan 30; 28(1).
-
"This needs to be told to everyone": Content analysis of written immediate responses from an online experiment examining health warning messages about alcohol consumption and breast cancer risk. PLoS One. 2025; 20(12):e0338687.
-
Association Between Regional Competition and Cancer Screening Rates at Federally Qualified Health Centers. J Ambul Care Manage. 2026 Jan-Mar 01; 49(1):E40-E48.
-
Digitally Mediated Occupational Therapy to Increase Physical Activity in Urban and Rural Breast Cancer Survivors: Protocol for a Single-Arm Feasibility Trial. JMIR Res Protoc. 2025 Sep 26; 14:e73554.
-
Impact of Second Opinions on Time to Treatment of Breast Cancer. Ann Surg Oncol. 2025 Oct; 32(11):8286-8294.
-
Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression. FASEB J. 2025 Jul 31; 39(14):e70872.
-
Breast Cancer Patient Treatment Experience at a National Cancer Institute-Designated Cancer Center Before Formal Navigation Integration. Am J Clin Oncol. 2025 Sep 01; 48(9):458-459.
-
Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysis. Cancer Lett. 2025 Sep 01; 627:217825.
-
Synergistic Therapeutic Effects of Prussian Blue Erbium-Doped Hydroxyapatite Nanoparticles in Photothermal Photodynamic Cancer Therapy. ACS Biomater Sci Eng. 2025 May 12; 11(5):2639-2652.
-
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.